04/25/2024
6:00 AM | Aclaris Therapeutics (Filer)
| Form DEF 14A | |
04/25/2024
6:01 AM | Aclaris Therapeutics (Filer)
| Form DEFA14A | |
04/25/2024
6:02 AM | Aclaris Therapeutics (Filer)
| Form ARS | |
04/03/2024
4:00 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:08 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
6:30 AM | Aclaris Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2024
6:14 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
02/14/2024
7:32 PM | Aclaris Therapeutics (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024
9:30 AM | Aclaris Therapeutics (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
| Form SC 13G/A | |
02/13/2024
1:24 PM | Aclaris Therapeutics (Subject)
Foresite Capital Fund IV, L.P. (Filed by)
| Form SC 13G/A | |
02/08/2024
10:14 AM | Aclaris Therapeutics (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SC 13G/A | |
02/08/2024
9:47 AM | Aclaris Therapeutics (Issuer)
Leonard Braden Michael (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/05/2024
6:29 PM | Aclaris Therapeutics (Issuer)
Loerop James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:31 PM | Aclaris Therapeutics (Issuer)
Monahan Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:36 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:27 PM | Aclaris Therapeutics (Issuer)
Balthaser Kevin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
3:31 PM | Aclaris Therapeutics (Filer)
| Form 8-K/A | |
01/19/2024
6:30 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/16/2024
4:24 PM | Aclaris Therapeutics (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SC 13G | |
12/11/2023
3:25 PM | Aclaris Therapeutics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G | |
12/11/2023
8:36 AM | Aclaris Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/24/2023
12:49 PM | Aclaris Therapeutics (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
| Form SC 13G | |
11/13/2023
6:42 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
6:30 AM | Aclaris Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2023
6:15 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2023
3:28 PM | Aclaris Therapeutics (Issuer)
Monahan Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
3:06 PM | Aclaris Therapeutics (Subject)
Monahan Joseph (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2023
7:00 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/07/2023
3:16 PM | Aclaris Therapeutics (Issuer)
Balthaser Kevin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2023
4:08 PM | Aclaris Therapeutics (Issuer)
Balthaser Kevin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2023
3:14 PM | Aclaris Therapeutics (Subject)
CITADEL ADVISORS LLC (Filed by)
| Form SC 13G | |
08/28/2023
3:39 PM | Aclaris Therapeutics (Issuer)
Loerop James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2023
3:31 PM | Aclaris Therapeutics (Issuer)
Monahan Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2023
3:20 PM | Aclaris Therapeutics (Subject)
Monahan Joseph (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2023
6:15 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2023
6:30 AM | Aclaris Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/22/2023
3:30 PM | Aclaris Therapeutics (Issuer)
Monahan Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
3:32 PM | Aclaris Therapeutics (Issuer)
Molineaux Christopher P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:31 PM | Aclaris Therapeutics (Issuer)
Molineaux Christopher P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:31 PM | Aclaris Therapeutics (Subject)
Monahan Joseph (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2023
3:15 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad) 4x Better than Bitcoin
Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> |
06/05/2023
4:02 PM | Aclaris Therapeutics (Issuer)
Molineaux Christopher P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
4:04 PM | Aclaris Therapeutics (Issuer)
GOWEN MAXINE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
3:53 PM | Aclaris Therapeutics (Issuer)
SCHIFF ANDREW N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
3:57 PM | Aclaris Therapeutics (Issuer)
Reasons Bryan M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
3:45 PM | Aclaris Therapeutics (Issuer)
Mehra Anand (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
3:50 PM | Aclaris Therapeutics (Issuer)
Powell Andrew Kenneth William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2023
3:18 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2023
6:15 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2023
6:30 AM | Aclaris Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
